# EDGAR Filing Document

**Accession Number:** 0001826470
**File Stem:** 0000000000-23-000698
**Filing Date:** 2023-1
**Character Count:** 8226
**Document Hash:** 83f83a2539e9a4cd8fb911a441aa7511
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-23-000698.hdr.sgml**: 20230328

**ACCESSION NUMBER**: 0000000000-23-000698

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230123

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Petco Health & Wellness Company, Inc.
- **CENTRAL INDEX KEY:** 0001826470
- **STANDARD INDUSTRIAL CLASSIFICATION:** RETAIL-RETAIL STORES, NEC [5990]
- **IRS NUMBER:** 811005932
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0128

**FILING VALUES:**
- **FORM TYPE:** UPLOAD

**BUSINESS ADDRESS:**
- **STREET 1:** 10850 VIA FRONTERA
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92127
- **BUSINESS PHONE:** 1-858-453-7845

**MAIL ADDRESS:**
- **STREET 1:** 10850 VIA FRONTERA
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92127

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PET Acquisition LLC
- **DATE OF NAME CHANGE:** 20200929

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Petco Acquisition LLC
- **DATE OF NAME CHANGE:** 20200929
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001564590-22-011685

## Text-Extract

```

United States securities and exchange commission logo

                             January 23, 2023

       Brian LaRose
       Chief Financial Officer
       Petco Health & Wellness Company, Inc.
       10850 Via Frontera
       San Diego, CA 92127

                                                        Re: Petco Health &
Wellness Company, Inc.
                                                            Form 10-K for the
Fiscal Year Ended January 29, 2022
                                                            Filed March 24,
2022
                                                            File No. 001-39878

       Dear Brian LaRose:

              We have limited our review of your filing to the financial
statements and related
       disclosures and have the following comments. In some of our comments, we
may ask you to
       provide us with information so we may better understand your disclosure.

              Please respond to these comments within ten business days by
providing the requested
       information or advise us as soon as possible when you will respond. If
you do not believe our
       comments apply to your facts and circumstances, please tell us why in
your response.

                                                        After reviewing your
response to these comments, we may have additional comments.

       Form 10-K for the Fiscal Year Ended January 29, 2022

       Management's Discussion and Analysis of Financial Condition and Results
of Operations
       Fiscal 2021 (52 weeks) Compared with Fiscal 2020 (52 weeks)
       Net Sales and Comparable Sales, page 49

   1.                                                   Please disclose how the
impact of changes in pricing in your different product categories
                                                        and average transaction
amount has resulted in the15.4% increase in pet care center
                                                        merchandise for the
fiscal year ended January 29, 2022. Refer to Item 303(b)(2)(iii) of
                                                        Regulation S-K.
   2.                                                   We note several
instances in which two or more factors are cited as a cause of a variance
                                                        in financial statement
items, like net sales. Please quantify each factor cited so that
                                                        investors may
understand the magnitude and relative impact of each. Refer to section
                                                        501.04 of the staff   s
Codification of Financial Reporting Releases for guidance.
 Brian LaRose
FirstName  LastNameBrian LaRose Inc.
Petco Health & Wellness Company,
Comapany
January 23,NamePetco
            2023     Health & Wellness Company, Inc.
January
Page 2 23, 2023 Page 2
FirstName LastName
Reconciliation of Non-GAAP Financial Measures
Adjusted EBITDA, page 51

3.       Please tell us how the adjustments for store pre-opening expenses,
store closing expenses,
         and non-recurring costs to arrive at Adjusted EBITDA are in compliance
with Question
         100.01 of the Compliance and Disclosure Interpretations on Non-GAAP
Financial
         Measures (C&DI   s). Additionally, please tell us how the adjustment
for non-cash
         occupancy-related costs complies with Question 100.04 of the C&DI   s.
Your response
         should specifically identify and discuss each of these adjustments
individually.
       In closing, we remind you that the company and its management are
responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review,
comments, action or
absence of action by the staff.

       You may contact Robert Shapiro at 202-551-3273 or Theresa Brillant at
202-551-3307
with any questions.

                                                              Sincerely,

                                                              Division of
Corporation Finance
                                                              Office of Trade &
Services

```

### Attached PDF Documents

**Attachment 1:** `filename1`

DIVISION OF
CORPORATION FINANCE

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

January 23, 2023

Brian LaRose
Chief Financial Officer
Petco Health & Wellness Company, Inc.
10850 Via Frontera
San Diego, CA 92127

**Re: Petco Health & Wellness Company, Inc.**
**Form 10-K for the Fiscal Year Ended January 29, 2022**
**Filed March 24, 2022**
**File No. 001-39878**

Dear Brian LaRose:

We have limited our review of your filing to the financial statements and related disclosures and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure.

Please respond to these comments within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe our comments apply to your facts and circumstances, please tell us why in your response.

After reviewing your response to these comments, we may have additional comments.

Form 10-K for the Fiscal Year Ended January 29, 2022

Management's Discussion and Analysis of Financial Condition and Results of Operations
Fiscal 2021 (52 weeks) Compared with Fiscal 2020 (52 weeks)

Net Sales and Comparable Sales, page 49

1. Please disclose how the impact of changes in pricing in your different product categories and average transaction amount has resulted in the 15.4% increase in pet care center merchandise for the fiscal year ended January 29, 2022. Refer to Item 303(b)(2)(iii) of Regulation S-K.
2. We note several instances in which two or more factors are cited as a cause of a variance in financial statement items, like net sales. Please quantify each factor cited so that investors may understand the magnitude and relative impact of each. Refer to section 501.04 of the staff's Codification of Financial Reporting Releases for guidance.

Brian LaRose
Petco Health & Wellness Company, Inc.
January 23, 2023
Page 2

# Reconciliation of Non-GAAP Financial Measures

# Adjusted EBITDA, page 51

3. Please tell us how the adjustments for store pre-opening expenses, store closing expenses, and non-recurring costs to arrive at Adjusted EBITDA are in compliance with Question 100.01 of the Compliance and Disclosure Interpretations on Non-GAAP Financial Measures (C&DI's). Additionally, please tell us how the adjustment for non-cash occupancy-related costs complies with Question 100.04 of the C&DI's. Your response should specifically identify and discuss each of these adjustments individually.

In closing, we remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

You may contact Robert Shapiro at 202-551-3273 or Theresa Brillant at 202-551-3307 with any questions.

Sincerely,

Division of Corporation Finance
Office of Trade & Services